Skip to content

the efficacy of pullulan phosphate in colorectal EMR

The efficacy of pullulan phosphate as a submucosal injection material for endoscopic mucosal resection of colorectal polyps

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCT1062240071
Enrollment
224
Registered
2024-10-23
Start date
2024-11-18
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

colorectal polyps

Interventions

EMR for the target lesion using pullulan phospjate or saline solution according to the allocation. Pathology specimens will be taken evaluate the margins and the depth of submucosal layer. An outpatie

Sponsors

Yamasaki Yasushi
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: i) non-stalked colorectal polyps between 6 mm and 20 mm in size ii) 18 years of age or older iii) Patienst who have been fully informed consent.

Exclusion criteria

Exclusion criteria: i) Suspected of invasive cancer ii) Pedunculated polyps (Type 0-Ip) iii) Inflammatory Bowel Disease (IBD) iv) Familial Adenomatous Polyposis (FAP) v) Patients who have difficulty with withdrawal of medication in accordance with antithrombotic drug guideline vi) Severe hepatic, renal, or cardiac dysfunction vii) Pregnant, possibly pregnant, or lactating women viii) Patients who judged as inappropriate candidate by the chief medical examine

Design outcomes

Primary

MeasureTime frame
Complete resection and no additional submucosal injection rate

Secondary

MeasureTime frame
i) En bloc resection rate ii) Adverse events iii) Resection time iv) Resection depth v) Injection volume vi) Swelling

Contacts

Public ContactJunki Toyosawa

Okayama University Hospital

p6yr1rdk@s.okayama-u.ac.jp+81-86-235-7219

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026